TY - JOUR
T1 - ERBIN is a new SARA-interacting protein: competition between SARA and SMAD2 and SMAD3 for binding to ERBIN
AU - Sflomos, G.
AU - Kostaras, E.
AU - Panopoulou, E.
AU - Pappas, N.
AU - Kyrkou, A.
AU - Politou, A. S.
AU - Fotsis, T.
AU - Murphy, C.
N1 - Journal article Journal of cell science J Cell Sci. 2011 Aug 30.
PY - 2011
Y1 - 2011
N2 - SARA, an early endosomal protein, plays a key role in TGFbeta signalling, as it presents SMAD2 and SMAD3 for phosphorylation by the activated TGFbeta receptors. Here, we show that ERBIN is a new SARA-interacting protein that can be recruited by SARA to early endosomes. ERBIN was recently shown to bind and segregate phosphorylated SMAD2 and SMAD3 (SMAD2/3) in the cytoplasm, thereby inhibiting SMAD2/3-dependent transcription. SARA binds to ERBIN using a new domain, which we have called the ERBID (ERBIN-binding domain), whereas ERBIN binds to SARA using a domain (amino acids 1208-1265) that also interacts with SMAD2 and SMAD3, which we have called the SSID (SARA- and SMAD-interacting domain). We additionally show that SARA competes with SMAD2/3 for binding to ERBIN. In agreement, overexpression of SARA or the ERBID peptide reverses the inhibitory effect of ERBIN on SMAD2/3-dependent transcription. Taken together, these data suggest that the response of cells to TGFbeta and activin A can be influenced by the relative concentrations of SARA, ERBIN and SMAD2/3.
AB - SARA, an early endosomal protein, plays a key role in TGFbeta signalling, as it presents SMAD2 and SMAD3 for phosphorylation by the activated TGFbeta receptors. Here, we show that ERBIN is a new SARA-interacting protein that can be recruited by SARA to early endosomes. ERBIN was recently shown to bind and segregate phosphorylated SMAD2 and SMAD3 (SMAD2/3) in the cytoplasm, thereby inhibiting SMAD2/3-dependent transcription. SARA binds to ERBIN using a new domain, which we have called the ERBID (ERBIN-binding domain), whereas ERBIN binds to SARA using a domain (amino acids 1208-1265) that also interacts with SMAD2 and SMAD3, which we have called the SSID (SARA- and SMAD-interacting domain). We additionally show that SARA competes with SMAD2/3 for binding to ERBIN. In agreement, overexpression of SARA or the ERBID peptide reverses the inhibitory effect of ERBIN on SMAD2/3-dependent transcription. Taken together, these data suggest that the response of cells to TGFbeta and activin A can be influenced by the relative concentrations of SARA, ERBIN and SMAD2/3.
M3 - Article
SN - 1477-9137
VL - 124
SP - 3209
EP - 3222
JO - J. Cell Sci
JF - J. Cell Sci
ER -